The store will not work correctly when cookies are disabled.
3-((2,5-Dioxo-4-(2-phenoxyphenyl)-2,5-dihydro-1H-pyrrol-3-yl)-amino)benzonitrile
ID: ALA4877169
PubChem CID: 164625998
Max Phase: Preclinical
Molecular Formula: C23H15N3O3
Molecular Weight: 381.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1cccc(NC2=C(c3ccccc3Oc3ccccc3)C(=O)NC2=O)c1
Standard InChI: InChI=1S/C23H15N3O3/c24-14-15-7-6-8-16(13-15)25-21-20(22(27)26-23(21)28)18-11-4-5-12-19(18)29-17-9-2-1-3-10-17/h1-13H,(H2,25,26,27,28)
Standard InChI Key: KFWIRUUNWBMPHH-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
17.5975 -2.5992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4146 -2.5992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6690 -1.8225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0061 -1.3404 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3473 -1.8225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1730 -3.2975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3537 -3.2776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9286 -3.9762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3218 -4.6950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1443 -4.7109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5656 -4.0118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8942 -3.2609 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7075 -3.2605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1127 -3.9670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9252 -3.9669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3323 -3.2619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9210 -2.5554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1098 -2.5589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4466 -1.5710 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5700 -1.5703 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.3338 -4.6746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7424 -5.3824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9619 -2.5605 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1450 -2.5412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7584 -1.8233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9422 -1.8036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5161 -2.5020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9122 -3.2216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7272 -3.2377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
6 1 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
3 19 2 0
5 20 2 0
15 21 1 0
21 22 3 0
7 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 381.39 | Molecular Weight (Monoisotopic): 381.1113 | AlogP: 3.83 | #Rotatable Bonds: 5 |
Polar Surface Area: 91.22 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.54 | CX Basic pKa: ┄ | CX LogP: 3.30 | CX LogD: 3.30 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.66 | Np Likeness Score: -0.70 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |